Connecting Healthcare Professionals to Scientific Information

UCBCOMPASS® provides scientific education and
medical information on UCB medicines used to treat
certain immune-mediated inflammatory conditions.

Search Congress Materials
Announcements

UCB continues to proactively monitor the COVID-19 situation. To learn more about UCB's preparedness, click here.

FDA issues a Complete Response letter to the Biologics License Application for bimekizumab for the treatment of moderate-to-severe plaque psoriasis. Learn more.

The Women's Health Fellowship Program began accepting applications for the 2024-2025 fellowship year on May 8th. Learn More

Listen to Podcasts

Gain insights as scientists, medical experts, and patients discuss advances and unmet needs in inflammatory autoimmune conditions.

/disease-education/scientific-education-podcasts
Find Publications

Review the latest UCB research, including original articles, from peer-reviewed sources.

/our-science/publications
Opportunities for Investigators

Submit a study concept, request access to patient-level data from UCB trials, or become a UCB clinical trial investigator.

/our-science/research-support